Whistleblowing

Generi Biotech s.r.o. prides itself on compliance not only with applicable Czech and EU legislation but also with ethical values in its activities.

Even in connection with obtaining an important European certification, we emphasize proper compliance with procedures, setting up processes, setting standards of social responsibility and requiring professionalism in dealing with customers and suppliers, and gradually working to improve the working conditions of our employees.

In connection with the EU Regulation, Directive (EU) 2019/1937 of the EU Parliament and Council of 23 October 2019 on the protection of individuals, the Company is setting up an internal whistleblowing system, which not only gives us the opportunity to effectively protect whistleblowers and meet related legal requirements but also to improve the Company’s culture and enhance its credibility.

Pursuant to Act No. 171/2023 Coll., the Whistleblower Protection Act, an individual may provide us with constructive feedback through the communication channels listed below if he or she has encountered any violation thereof in connection with work or other similar activity, or if it concerned a person with whom the whistleblower has been or is in contact in connection with the performance of work or other similar activity.

We exclude the acceptance of notifications from a person who does not perform work or other similar activity for the obliged entity as referred to in Section 2(3)(a), (b), (h) or (i).

If you have any suspicions of possible wrongdoing by our employees related to the performance of their work or other similar activities, you may report to us using the following procedure:

• To report whistleblowing, you can e-mail whistleblowing@generi-biotech.com or call +420 771 241 767.
• The contact person for this communication is Kateřina Bařina Vyleťalová, HR Manager, Generi Biotech s.r.o.

To properly investigate a case, we need to know

• Your name, surname and date of birth (or other information from which the identity of the whistleblower can be deduced),
• Furthermore, we need contact details: telephone, e-mail for quick resolution of the case.

Generi Biotech s.r.o. declares the inadmissibility of retaliatory measures against the persons who made the notification.

This does not apply if the person has knowingly made a false report. The notification must relate to the areas defined in Act No. 171/2023 Coll. on the protection of whistleblowers.